Sutro Biopharma Inc (NASDAQ:STRO) traded at $4.39 at close of the session on Tuesday, April 09, made a downward move of -7.38% on its previous day’s price.
Looking at the stock we see that its previous close was $4.74 and the beta (5Y monthly) reads 0.95 . In terms of its 52-week price range, STRO has a high of $6.13 and a low of $2.01. The company’s stock has lost about -6.00% over that past 30 days.
Sutro Biopharma Inc has a market cap of $337.68 million and is expected to release its quarterly earnings report on May 13, 2024 – May 17, 2024. Estimates by analysts give the company expected earnings per share (EPS) of -$0.92, with the EPS growth for the year raised at -$3.3 for 2024 and -$3.26 for next year. These figures represent -85.40% and 1.20% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $11.92 million, with a low of $5 million and a high of $24.65 million. The median projection represents growth adding up to -5.90% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $55.83 million, or -63.70% down from figures reported last year.
There have been 1 upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the STRO stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 50% Buy. Long term indicators on average place the stock in the category of 100% Buy.
Looking further, we note the current price level is 0.44% off its SMA20 and -3.75% from its 50-day simple moving average. The RSI (14) is pointing at 47.58 while the volatility over the past week is 11.03% and jumps to 11.17% over the past one month. The beta value is 1.00, while the average true range (ATR) is currently pointing at 0.50.
Coming back to Sutro Biopharma Inc (NASDAQ:STRO), we note that the average 3-month trading volume was 997.19K, while that of the preceding 10-day period stands at 2.09 million. Current shares outstanding are 76.92 million.
The insiders hold 4.17% of the company’s shares while institutions hold 80.25%. The data shows that short shares as of Mar 15, 2024, stood at 2.32 million at a short ratio of 2.68. This represents a 3.81% short interest in shares outstanding on Mar 15, 2024. Shares short fall in March from the previous month at 2.67 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 2.33% up in year-to-date price movement.
